Mouse is a popular model system because it is a mammal with sophisticated genetic tools and significant genetic resources. The prospect of the mice as a model for exploring human pathophysiology and disease progression and for developing drugs is likely to be further widened by the introduction of new models such as immunedeficient and humanizing mouse in which human tissues and cells or genes are reconstituted. With 99% of their genes shared with humans, new possibilities were opened for genetic testing. Furthermore, the conservation of genetic association within the mice and human genomes with respect to the encoded genes and their alignment along chromosomes has been a great advantage in the identification of potentially conforming homologous mutations and disease genes.
Biomedical research has taken a front seat in the healthcare and pharmaceutical industries, to a point where a nation’s research and development landscape can be gauged by its level of investment in biomedical research. The past decade has consequently witnessed a staggering rise in biomedical research in most countries, both developed and developing. A significant part of this research investment typically goes into animal models, more specifically, mice models. This forms the primary driver for the global mice models market.
PDF For Full Details and Benifits of Mice Model Market: http://bit.ly/2cQgFqf
This report studies the global mice model market from five perspectives: by type of model, application, services, and geography. Based on type of model, the market has been segmented into hybrid/congenic, transplantation mouse, transgenic, knockout, carcinogen-induced and spontaneous mouse, outbred, inbred, and conditioned/surgically modified. Based on application, the market has been segmented into immunology, central nervous system, oncology, cardiovascular, diabetes, and metabolism & regulation.
The resultant effect on the competitive landscape for the global mice models market is a significant growth in the number of regional players in the emerging economies. They pose a direct threat to the globally prominent players that are trying to invest in the opportunities that these regions hold.
Advancements in Mice Model Types and Services Add to Research Scope and Capabilities
“The ALS Association had recently shown the use of mutated mice models for the study of the disease,” states a TMR analyst. “This is only one of the many examples that can show that the recent advancements in mice model types and services have not only added to the strength of existing research processes, but have also expanded the scope of mice model use within other medical research fields.”
New mice models are found to be acceptable in the studies of advanced diseases, a fact which is greatly driving the demand for mice models. They can now be used in advanced research such as lung disease repair.
The integral nature of the mice models market with the pharmaceutical and biomedical fields has allowed companies from these industries to form alliances that can even revolve around further advancing the mice models types and services in the future.
Growing Scope of Alternative Technologies Restrains Use of Mice Models
A lot of companies are currently seeking non-animal test methods for their research processes in order to either eliminate animal use completely or to restrict it as much as possible. Alternatives include solutions such as the Irritation Assay System which is a simplified procedure in a test tube used for skin irritation, or even human skin culture.
A lot of these alternatives are not only cheaper but also provide a faster and more accurate conclusion formation process. This complements the reduction in use of animal models due to the growing protests by people against their use.
In another alternative, professionals are adopting computer-generated simulations to test their processes, further reducing the need for animal models.
North America Retains Leading Demand for Mice Models While APAC Demand Soars
The global market for mice models is expected to be evaluated at US$1.79 bn by the end of 2023.
North America has consistently been a key region in terms of demand for mice models. By the end of 2023, this region is expected to generate a revenue of US$785.4 mn. Meanwhile, the demand for mice models is expected to expand at a CAGR of 11.1% in Asia Pacific, from 2015 to 2023.
View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/mice-model-market.html
An immense demand for genetically engineered mice models is expected to put this service type in the leading position by 2023, with an expected revenue of US$155.2 mn. Mouse breeding and re-derivation have so far been the more popular mice model service types but are likely to be replaced by genetically engineered models soon.
Inbred mice models have consistently been the more popular mice model types. By the end of 2023, the revenue earned by the inbred mice model segment is expected to reach US$340.6 mn.
The key players in the global mice model market are TransGenic, Inc., The Jackson Laboratory, SAGE Labs, Lexicon Pharmaceuticals, Taconic Biosciences, Inc., ImmunoGenes AG, Harlan Laboratories, Inc., GenOway S.A., Deltagen, Inc., Crescendo Biologics Limited, and Charles River Laboratories.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
For more information:
Last updated on: 20/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.